MoneyWorks4Me

Biocon informs about credit rating

11 Mar 2022 Evaluate
Biocon has informed that the Company has received a rating letter from ICRA on March 10, 2022, wherein ICRA has placed its ICRA AA+ and ICRA A1+ ratings on the long term and short-term banking facilities of the Company on 'Watch with Developing Implications'. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..